These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 618907

  • 1. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM, Manning JM.
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA, Kale MP, Tarassoff PG, Woods M, Lessin LS.
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM, Acharya AS.
    Am J Pediatr Hematol Oncol; 1984 Oct; 6(1):51-4. PubMed ID: 6711764
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
    Ueno H, Yatco E, Benjamin LJ, Manning JM.
    J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sickling times of individual erythrocytes at zero Po2.
    Zarkowsky HS, Hochmuth RM.
    J Clin Invest; 1975 Oct; 56(4):1023-34. PubMed ID: 239967
    [Abstract] [Full Text] [Related]

  • 13. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST.
    Blood Cells; 1982 Oct; 8(2):337-43. PubMed ID: 6130805
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sickling reversed and blocked by urea in invert sugar.
    Nalbandian RM, Henry RL, Barnhart MI, Nichols BM, Camp FR, Wolf PL.
    Am J Pathol; 1971 Aug; 64(2):405-22. PubMed ID: 5142273
    [Abstract] [Full Text] [Related]

  • 17. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST.
    Blood Cells; 1982 Aug; 8(1):79-87. PubMed ID: 7115980
    [Abstract] [Full Text] [Related]

  • 18. Established and experimental treatments for sickle cell disease.
    De Franceschi L, Corrocher R.
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.